XML 121 R44.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders’ Equity (Details Narrative) - USD ($)
 6 Months Ended 9 Months Ended 12 Months Ended
Apr. 04, 2025
Mar. 21, 2025
Feb. 25, 2025
Feb. 06, 2025
Oct. 01, 2024
Sep. 16, 2024
Jan. 04, 2024
Oct. 31, 2023
Jun. 30, 2025
Jun. 30, 2024
Sep. 30, 2024
Dec. 31, 2024
Dec. 10, 2024
Dec. 31, 2023
Dec. 31, 2022
Feb. 26, 2025
Jul. 10, 2023
May 11, 2023
May 10, 2023
Reverse stock split             1 for 20                        
Common stock shares issued                 9,092,518     8,092,518   140,264,240          
Common stock shares outstanding                 9,092,518     8,092,518   140,264,240          
Common stock, shares authorized                           7,066,772          
Common stock under the Plan, for services, value                 $ 190,000                    
Stock based compensation expense                 $ 0 $ 0                  
Common stock, shares authorized                 200,000,000     200,000,000              
Common stock, par value                 $ 0.02     $ 0.02              
Preferred stock, shares authorized                 47,000     47,000              
Preferred stock, shares Issued                 0     0              
Preferred stock, shares outstanding                 0     0              
Stockholders' Equity Note, Stock Split               reverse stock split of 1 for 55                      
Number of shares owned                                 4    
Purchase price per share         $ 3.00                            
Number of shares acquired value     $ 1,150,000                                
Number of shares acquired     545,024                                
Shares issued                 100,000             36,433      
Stock based compensation, option grants         880,000                            
Proceeds from grants         $ 2,640,000                            
Fair value grants         $ 50,000                            
Selling, General and Administrative Expenses [Member]                                      
Stock based compensation expense                 $ 4,000     $ 19,000              
Impact Bio Medical Inc [Member]                                      
Common stock shares issued                     11,503,955     10,000,000       0 125,073,621
Common stock shares outstanding                     11,503,955     10,000,000       0 125,073,621
Number of shares sold 890,800 499,800                                  
Number of shares sold, value $ 845,000 $ 1,500,000                                  
Common stock, shares authorized                                   3,877,282,251 4,000,000,000
Common stock, par value                                     $ 0.001
Preferred stock, shares authorized                                     100,000,000
Preferred stock, shares Issued                     60,496,041     60,496,041         0
Preferred stock, shares outstanding                     60,496,041     60,496,041         0
Number of shares owned                                 1    
Impact Bio Medical Inc [Member] | IPO [Member]                                      
Number of shares sold 115,600                                    
Number of shares sold, value $ 63,000                                    
DSS BioHealth Securities, Inc. [Member] | Series A Convertible Preferred Stock [Member]                                      
Common stock, shares authorized               60,496,041                      
Impact BioMedical, Inc. [Member]                                      
Reverse stock split               reverse stock split of 1 for 55                      
Common stock shares issued                           3,877,282,251 3,877,282,251        
Common stock shares outstanding                           3,877,282,251 3,877,282,251        
Common stock, shares authorized                           70,496,041 70,496,041        
Impact BioMedical, Inc. [Member] | IPO [Member]                                      
Common stock shares issued                     11,497,703                
Common stock shares outstanding                     11,497,703                
Initial public offering           1,500,000                          
Number of shares sold                     1,500,000                
Common stock, par value           $ 0.001                          
Purchase price per share           $ 3.00                          
Allowance and expenses                 3,726,000                    
Cost and expense                 $ 1,500,000                    
Stock descrption                 A final prospectus relating to this Offering was filed with the Commission on September 16, 2024. The shares of Common Stock were approved to list on the NYSE American under the symbol “IBO” and began trading there on September 16, 2024. The Company also issued warrants to the Representative and its affiliates (the “Representative’s Warrants”) warrants to purchase the number of shares of Common Stock in the aggregate equal to 5% of the Common Stock to be issued and sold in this offering (including any Shares of Common Stock sold upon exercise of the over-allotment option, if applicable). The Representative’s Warrants are exercisable for a price per share equal to 125% of the public offering price. The warrants are exercisable at any time, in whole or in part, commencing nine (9) months from the date of commencement of sales of the offering and ending on the third anniversary thereof                    
Sale of stock number of shares issued in remaining                     9,997,703                
Equity Incentive Plan [Member]                                      
Common stock under the Plan, for services       1,000,000                              
Common stock under the Plan, for services, value       $ 870,000                              
Common Stock [Member]                                      
Common stock under the Plan, for services                                    
Common stock under the Plan, for services, value                                    
Common Stock [Member] | DSS BioHealth Securities, Inc. [Member] | Maximum [Member]                                      
Ownership percentage               88.00%                      
Common Stock [Member] | DSS BioHealth Securities, Inc. [Member] | Minimum [Member]                                      
Ownership percentage               12.00%                      
Common Stock [Member] | DSS BioHealth Securities, Inc. [Member]                                      
Common stock, shares authorized               60,496,041                      
Securities Purchase Agreement [Member] | Common Stock [Member]                                      
Initial public offering                         820,597            
Number of value common stock                         $ 803,000            
Securities Purchase Agreement [Member] | Common Stock [Member] | Heng Fai Ambrose Chan [Member]                                      
Initial public offering                         205,149            
Number of value common stock                         $ 197,000